{"id":"https://openalex.org/W2806233062","doi":"https://doi.org/10.1186/s12991-018-0190-6","title":"An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder","display_name":"An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder","alternate_titles":[],"publication_year":2018,"publication_date":"2018-05-11","ids":{"openalex":"https://openalex.org/W2806233062","doi":"https://doi.org/10.1186/s12991-018-0190-6","mag":"2806233062","pmid":"https://pubmed.ncbi.nlm.nih.gov/29760763","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5946398"},"language":"en","primary_location":{"id":"doi:10.1186/s12991-018-0190-6","doi":"https://doi.org/10.1186/s12991-018-0190-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12991-018-0190-6","pdf_url":"https://annals-general-psychiatry.biomedcentral.com/track/pdf/10.1186/s12991-018-0190-6","source":{"id":"https://openalex.org/S196365082","display_name":"Annals of General Psychiatry","issn_l":"1744-859X","issn":["1744-859X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of General Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2806233062"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://annals-general-psychiatry.biomedcentral.com/track/pdf/10.1186/s12991-018-0190-6","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Anish Shah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Anish Shah","raw_affiliation_strings":["Siyan Clinical Corporation, 480 Tesconi Dr., Santa Rosa, CA, 95401, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Siyan Clinical Corporation, 480 Tesconi Dr., Santa Rosa, CA, 95401, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086079940","display_name":"Joanne Northcutt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joanne Northcutt","raw_affiliation_strings":["Northcutt Consulting, LLC, Orlando, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northcutt Consulting, LLC, Orlando, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3090,"currency":"USD","value_usd":3090},"apc_paid":{"value":3090,"currency":"USD","value_usd":3090},"fwci":3.0125,"has_fulltext":true,"cited_by_count":28,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.89916222,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"17","issue":"1","first_page":"19","last_page":"19"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10786","display_name":"Maternal Mental Health During Pregnancy and Postpartum","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vortioxetine","display_name":"vortioxetine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/panic-disorder","display_name":"panic disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/panic-attacks","display_name":"panic attacks","score":0.7039999961853027},{"id":"https://openalex.org/keywords/treatment-resistant-anxiety","display_name":"treatment-resistant anxiety","score":0.6039999723434448},{"id":"https://openalex.org/keywords/anxiolytic-efficacy","display_name":"anxiolytic efficacy","score":0.7870000004768372},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.8700000047683716},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.718999981880188},{"id":"https://openalex.org/keywords/agoraphobia","display_name":"agoraphobia","score":0.8889999985694885},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.5950000286102295}],"concepts":[{"id":"https://openalex.org/C2778034309","wikidata":"https://www.wikidata.org/wiki/Q3563148","display_name":"Vortioxetine","level":4,"score":0.9088248014450073},{"id":"https://openalex.org/C2776236459","wikidata":"https://www.wikidata.org/wiki/Q1278031","display_name":"Geriatric psychiatry","level":2,"score":0.8148876428604126},{"id":"https://openalex.org/C103709681","wikidata":"https://www.wikidata.org/wiki/Q1515727","display_name":"Psychopharmacology","level":2,"score":0.62850022315979},{"id":"https://openalex.org/C2777529043","wikidata":"https://www.wikidata.org/wiki/Q741713","display_name":"Panic disorder","level":3,"score":0.6018675565719604},{"id":"https://openalex.org/C2781035948","wikidata":"https://www.wikidata.org/wiki/Q1407263","display_name":"Forensic psychiatry","level":2,"score":0.5342860221862793},{"id":"https://openalex.org/C2777196872","wikidata":"https://www.wikidata.org/wiki/Q319877","display_name":"Alprazolam","level":3,"score":0.5308737754821777},{"id":"https://openalex.org/C188313352","wikidata":"https://www.wikidata.org/wiki/Q119697","display_name":"Off-label use","level":2,"score":0.5011394023895264},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.49830079078674316},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4410477876663208},{"id":"https://openalex.org/C2780712732","wikidata":"https://www.wikidata.org/wiki/Q208450","display_name":"Panic","level":3,"score":0.4124559760093689},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.37560179829597473},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.3290014863014221},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.24283617734909058},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.21375390887260437},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.13019707798957825}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1186/s12991-018-0190-6","doi":"https://doi.org/10.1186/s12991-018-0190-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12991-018-0190-6","pdf_url":"https://annals-general-psychiatry.biomedcentral.com/track/pdf/10.1186/s12991-018-0190-6","source":{"id":"https://openalex.org/S196365082","display_name":"Annals of General Psychiatry","issn_l":"1744-859X","issn":["1744-859X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of General Psychiatry","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4869028","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5946398","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5946398","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5946398/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ann Gen Psychiatry","raw_type":"Text"},{"id":"pmid:29760763","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29760763","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of general psychiatry","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:4d728e08f0da42cfa1f7da9bfa6c627f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4d728e08f0da42cfa1f7da9bfa6c627f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Annals of General Psychiatry, Vol 17, Iss 1, Pp 1-7 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12991-018-0190-6","doi":"https://doi.org/10.1186/s12991-018-0190-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12991-018-0190-6","pdf_url":"https://annals-general-psychiatry.biomedcentral.com/track/pdf/10.1186/s12991-018-0190-6","source":{"id":"https://openalex.org/S196365082","display_name":"Annals of General Psychiatry","issn_l":"1744-859X","issn":["1744-859X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of General Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310030","display_name":"Takeda Pharmaceuticals U.S.A.","ror":"https://ror.org/03bygaq51"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2806233062.pdf","grobid_xml":"https://content.openalex.org/works/W2806233062.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1560455169","https://openalex.org/W1967366594","https://openalex.org/W1993054571","https://openalex.org/W1999415524","https://openalex.org/W2001782289","https://openalex.org/W2006634280","https://openalex.org/W2009483986","https://openalex.org/W2012424074","https://openalex.org/W2019457751","https://openalex.org/W2050728144","https://openalex.org/W2054372128","https://openalex.org/W2058854656","https://openalex.org/W2071972290","https://openalex.org/W2072711370","https://openalex.org/W2080743141","https://openalex.org/W2081078008","https://openalex.org/W2084170778","https://openalex.org/W2129336638","https://openalex.org/W2139596642","https://openalex.org/W2139938825","https://openalex.org/W2146586149","https://openalex.org/W2153638161","https://openalex.org/W2157543356","https://openalex.org/W2169567597","https://openalex.org/W2186383960","https://openalex.org/W2286488054","https://openalex.org/W2297232523","https://openalex.org/W2322157847","https://openalex.org/W2468100861","https://openalex.org/W2766812746","https://openalex.org/W2994354972","https://openalex.org/W4211156221","https://openalex.org/W4229538982","https://openalex.org/W4240309230"],"related_works":["https://openalex.org/W2149625681","https://openalex.org/W2083750988","https://openalex.org/W2338686169","https://openalex.org/W1986211869","https://openalex.org/W2051155228","https://openalex.org/W2013422953","https://openalex.org/W2129162473","https://openalex.org/W1996298226","https://openalex.org/W2416701250","https://openalex.org/W4323534074"],"abstract_inverted_index":{"Background":[0],"Despite":[1],"the":[2,125,133,141,151,163,180,185],"current":[3],"treatments":[4],"available":[5],"for":[6,27,98,179],"panic":[7,20,136,188],"disorder":[8,30],"(PD),":[9],"as":[10,12],"many":[11],"one-third":[13],"of":[14,41,58,80,135,153,168,182,187],"patients":[15],"have":[16,36],"persistent":[17],"and":[18,31,49,85,91,155,166],"treatment-resistant":[19],"attacks.":[21],"Vortioxetine":[22],"is":[23],"an":[24,52],"approved":[25],"medicine":[26],"major":[28],"depressive":[29],"has":[32],"been":[33],"shown":[34],"to":[35,45],"anxiolytic":[37],"properties.":[38],"The":[39,61],"purpose":[40],"this":[42],"study":[43,62],"was":[44,64,122,138],"evaluate":[46],"its":[47],"efficacy":[48],"safety":[50],"in":[51,132,150,184],"adult":[53],"population":[54],"with":[55,67,76,100,140,143],"a":[56,77,107,147],"diagnosis":[57],"PD.":[59],"Methods":[60],"design":[63],"open":[65],"label":[66],"flexible":[68],"dose":[69],"strategies":[70],"(5,":[71],"10,":[72],"or":[73,101,104],"20":[74],"mg)":[75],"treatment":[78],"period":[79],"10":[81],"weeks.":[82],"27":[83],"male":[84],"female":[86],"subjects":[87],"aged":[88],"between":[89],"18":[90],"60":[92],"years,":[93],"who":[94,105],"met":[95],"DSM-IV":[96],"criteria":[97],"PD":[99],"without":[102],"agoraphobia,":[103],"had":[106],"Panic":[108],"Disorder":[109],"Severity":[110],"Scale":[111,165],"(PDSS)":[112],"score":[113],">":[114],"8":[115],"at":[116],"baseline":[117],"were":[118,160],"enrolled.":[119],"Statistical":[120],"significance":[121],"established":[123],"by":[124],"Student\u2019sTtest.":[126],"Results":[127],"A":[128],"statistically":[129],"significant":[130,157],"decrease":[131],"occurrence":[134],"attacks":[137],"measured":[139],"PDSS":[142],"vortioxetine.":[144],"In":[145],"addition,":[146],"moderate":[148],"improvement":[149],"quality":[152],"life":[154],"no":[156],"side":[158],"effects":[159],"observed":[161],"using":[162],"Quality-of-Life":[164],"Monitoring":[167],"Side":[169],"Effects":[170],"Scale,":[171],"respectively.":[172],"Conclusions":[173],"These":[174],"results":[175],"provide":[176],"some":[177],"support":[178],"use":[181],"vortioxetine":[183],"management":[186],"disorder.":[189],"Trial":[190],"registrationClinicalTrials.gov":[191],"ID#:":[192],"NCT02395510.":[193],"Registered":[194],"March":[195],"23,":[196],"2015,":[197],"https://clinicaltrials.gov/ct2/show/NCT02395510":[198]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2806233062","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-06-13T00:00:00"}
